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Background: Individuals with Down syndrome (DS) present increased susceptibility to infections and high preva-
lence of periodontal disease. The objective of this study is to evaluate the salivary concentrations of IL-1β, IL-6, 
IL-8, IL-10, TNFα and IL-12p70 of DS individuals and compare to cerebral palsy (CP) and normoactive patients 
(all with gingivitis). 
Material and Methods: Twenty-two individuals with DS, 24 with CP and 22 normoactive participated in this 
cross-sectional study. Salivary flow rate, osmolality rate, Oral Hygiene Index, Gingival Index (GI) and salivary 
inflammatory markers IL-1β, IL-6, IL-8, IL-10, TNFα and IL-12p70 were evaluated. Shapiro-Wilks, Chi-square, 
ANOVA One-Way and Kruskal Wallis tests were applied with significance level at 5%. 
Results: The groups were homogenous for gender, age, and IL12p70 cytokine (p>0.05). GI was significantly higher 
in DS compared to CP and healthy (p<0.05). CP presented reduced salivary flow and increased osmolality rate. CP 
showed significantly higher values for TNFα, IL10, and IL6 compared to DS and normoactive (p<0.05). DS and CP 
presented significantly higher values of IL-1β and IL8 compared to normoactive (p<0.05).
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Introduction
Down syndrome (DS) is a frequent genetic chromo-
somal disorder resulted from the presence of a third 
chromosome 21 or trisomy 21. Individuals with this 
condition have physical and functional changes such as 
intellectual disabilities, heart disease, changes in the im-
mune system that predispose to increased susceptibility 
to infections (1) and a high prevalence of periodontal 
disease (2).
Individuals with DS have higher prevalence and seve-
rity of periodontal disease than individuals without DS. 
Several factors contribute to development of periodontal 
disease in individuals with DS, which is classified as a 
clinical manifestation of a systemic disease that affect 
the periodontal supporting tissues (3). The difficulty in 
performing oral hygiene predisposes the accumulation 
of biofilm and thus the development of high levels of 
gingivitis (4). Another fact that could contribute to the 
presence of periodontal disease in individuals with DS 
is the impaired host-response (5).
Due to immunological deficiency in DS patients, the in-
fections are more severe, mainly in respiratory system 
explained by alterations in humoral immunity (5). The 
abnormalities of the immune system associated with DS 
include an imbalance in the subpopulations of T and B 
lymphocytes, with marked decrease of naive T lympho-
cytes, impaired mitogen-induced T cell proliferation, 
reduced neutrophil phagocytosis and chemotaxis and 
reduction in specific antibody responses during immu-
nizations (6) and larger production of inflammatory me-
diators (7).
Gingivitis is a reversible inflammatory process induced 
by the presence of microorganisms in the biofilm near 
the gingival margin (8). The presence of bacterial lipo-
polysaccharides triggers the inflammatory response of 
the host, activating polymorphonuclear leukocytes and 
the secretion of inflammatory mediators such as cyto-
kines and chemokines (9). Proinflammatory cytokines 
such as interleukin-1 beta (IL-1β), tumor necrosis fac-
tor alpha (TNFα) and interleukin-6 (IL-6) are released 
in response to these inflammatory and infectious sti-
muli (10).
Saliva has been used as a promising non-invasive diag-
nostic tool because it is an easily accessible fluid con-
taining proteins, immunoglobulins and formed elements 
of blood from the gingival tissues (11). The changes in 
the inflammatory mediators present in saliva reflect the 
Conclusions: Individuals with CP have higher risk to develop periodontal disease due to reduced salivary flow rate, 
increased salivary osmolality rate and elevated TNFα, IL-10, IL-6 compared to DS.
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changes that occur in gingival tissue (12). Most studies 
evaluated the inflammatory cytokines through collection 
of blood or gingival crevicular fluid in individuals with 
DS (13). There is a lack in the literature regarding sali-
vary cytokine levels in individuals with DS. This evalua-
tion is important because gingivitis is a disease of high 
prevalence in individuals with DS and proinflammatory 
cytokines determination may indicate the immunologi-
cal status of these individuals.
In this context, the objectives of this study were (i) to 
evaluate the salivary concentrations of IL-1β, IL-6, IL-
8, IL-10, TNFα and the p70 subunit of interleukin-12 
(IL-12p70) of DS individuals with gingivitis and com-
pare to individuals with cerebral palsy (CP) and healthy 
ones (both with gingivitis); (ii) to evaluate and compare 
salivary flow rate and osmolality values among these 
individuals. These comparisons were made since indivi-
duals with DS and CP present some degree of physical 
disability that could implicate in oral health issues (14). 
The hypothesis of the study was that individuals with 
DS present higher levels of IL-1β, IL-6, IL-8, IL-10, 
TNFα and the p70 subunit of interleukin-12 (IL-12p70) 
cytokines when compared to individuals with CP and 
normoactive, all with gingivitis.
Material and Methods
-Ethical statement
This study was reviewed and approved by the Re-
search Ethics Committee of the Centro Universitário 
de Volta Redonda (CoEPS) Brazil Platform, RJ Brazil 
(#194,615SP) and by the Research Ethics Committee 
of the Cruzeiro do Sul University - Brazil Platform, SP 
Brazil (#1,938,626).  Written informed consent was ob-
tained from the legal guardians of each participant after 
they were informed about the study. 
-Study design
A cross-sectional study was conducted with individuals 
with DS who were referred to Association of Parents 
and Friends of Exceptional (APAE) and with individuals 
with CP who received rehabilitation treatment at Assis-
tance Association for the Disabled Children (AACD).
-Subjects
A total of seventy-three individuals with a medical diag-
nosis of DS (ICD 10 Q90), 58 with a medical diagnosis 
of CP (ICD 10 G80), and 40 normoactive ones were in-
vited to participate in this study.
Inclusion criteria were individuals with diagnosis of DS, 
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CP and normoactive who presented gingival marginal 
bleeding (GI) at least 30% of the sites evaluated (15) 
and age between seven to 18 years old. Progressive or 
neurodegenerative lesions were excluded, as well as 
adolescents who were using any medication that inter-
fere with salivary secretion for at least 72 hours prior to 
salivary collection or had undergone surgical procedures 
to control the external flow of saliva. Individuals who 
did not collaborate with the salivary collection or had 
used an antibiotic in the last month, with symptoms of 
fever, flu, pains in the body or diarrhea at the moment of 
collection, or those with some inflammatory condition in 
the oral mucosa, such as aphthous ulcers were excluded 
from the study (16).
The following evaluations were performed: inflam-
matory markers in saliva, salivary flow and osmolality 
rates, Oral Hygiene Index (17) and Gingival Index (18).
-Saliva collection
Unstimulated saliva samples were collected in the den-
tal assessment sessions as previously described (12). 
Participants were asked to refrain from eating, drinking 
liquids or brushing their teeth for at least 1 hour prior 
to saliva collection. Whole saliva was collected using 
an absorbent cotton roller (Salivette®; Sarsted, Num-
brecht, Germany) positioned on the floor of the mouth 
for five minutes. The collection was performed with the 
individuals sitting comfortably in a bright and ventilated 
room. After collection, the Salivette® was centrifuged 
at 5,000 rpm for five minutes at 4°C (Hettich Centri-
fuge, model Universal 320R, Tuttlingen, Germany) and 
frozen in a freezer at -80°C. After thawing the samples, 
the salivary flow rate was determined by the ratio volu-
me (mL) produced for 5 minutes.
-Biomarker analysis
The analysis of cytokines in saliva was performed using 
a CBA Cytokine Inflammatory Kit (Becton Dickinson, 
CA, USA) for the detection of IL-1β, IL-6, IL-8, IL-10, 
IL-12p70 and TNFα. All analyses were performed in du-
plicate.
Briefly, 25 μl of fluorescent particles conjugated to anti-
bodies specific for each cytokine were added to 25 μl of 
the saliva and incubated for one hour at room temperatu-
re away from light. Subsequently, 25 μl of the secondary 
antibody conjugated to a fluorochrome was added to the 
mixture and incubated for two hours at room temperatu-
re. The results were compared to a standard curve with 
serially diluted cytokines. The particles were washed to 
remove the unbound antibodies, resuspended in wash 
buffer and analyzed using a BD Accuri (BD Bioscien-
ces). Data acquisition was performed using BD-Accuri 
C6 Software, and concentrations were determined using 
FCAP software v.3.0 (BD Biosciences).
-Saliva osmolality
Saliva osmolality was determined by cooling point de-
pression in an osmometer (Model Vapro Vapor Pressure 
Osmometer 5600; New Instrument, Washington, DC, 
USA) as previously described (16).
-Oral Hygiene Index 
Six teeth (four posterior and two anterior) were assessed 
and scored for each individual according to the Simpli-
fied Oral Hygiene Index (OHI-S) (17). For the posterior 
teeth, the first fully erupted tooth distal to the second 
premolar or primary molar was examined in each qua-
drant. For maxillary molars, the buccal surfaces were 
scored, and for mandibular molars, the lingual surfaces 
were scored. For anterior teeth, the labial surfaces of the 
maxillary right and mandibular left central incisors were 
scored. The OHI-S is a combination of visible plaque 
and oral calculus indices.
-Gingival index (GI)
The evaluation of the GI (18) was performed using a mi-
llimeter plastic periodontal probe (HuFriedy’s Colorvue 
PerioScreen Kit probe, Chicago, IL, USA), which was 
gently passed in the gingival margin of all teeth, in refe-
rence to the distobuccal papilla, the buccal margin, the 
mesiobuccal papilla and the lingual / palliative margin. 
Partially erupted teeth and residual roots were excluded 
without replacement. The index was calculated by the 
percentage of the sum of the individual values of each 
tooth divided by the number of faces examined. Were 
considered individuals with gingivitis, that ones who 
presented gingival marginal bleeding at least 30% of the 
total sites evaluated (15).
-Statistical Analyses
Analyses of descriptive statistics were performed to cha-
racterize the sample, calculate measures of central ten-
dency and variability for the quantitative variables. The 
normality assumption of the quantitative variables was 
evaluated using the Shapiro-Wilks test. When normal 
distribution was observed, parametric tests were perfor-
med. Otherwise, non-parametric tests were selected to 
determine the significance of intergroups differences. 
The Chi-square test was used to analyze the variables of 
gender, and Kruskal Wallis to analyze cytokines levels.
The ANOVA One-Way test (parametric data) was used 
to determine significant intergroups differences in rela-
tion to the periodontal condition and salivary parame-
ters studied. IBM SPSS Statistics (SPSS for Windows, 
Version 20.0, Armonk, NY: IBM Corp.) was used for all 
analyses, with a significance level of 5%. 
Results
The sample power was calculated using the means and 
standard deviations of TNFα between the groups of indi-
viduals with DS (Mean±SD: 1.45±1.92) and individuals 
with CP (Mean±SD: 7.26±3.22) (OpenEpi online; www.
openepi.com). The results showed that at the 95% confi-
dence interval, the G Power was 100%. 
The groups were homogenous for gender (p=0.457), age 
(p=0.328), and IL12p70 cytokine (p=0.322). Although, 
J Clin Exp Dent. 2020;12(5):e446-51.                                                                                                                                                                                               COX-1 and -2 in oral surgical model
e449
individuals with DS and CP did not differ regarding 
OHI-S, the percentage of GI was significantly higher 
in individuals with DS compared to CP and health ones 
(p-values<0.05) (Table 1).
Regarding salivary flow and osmolality rates, the CP 
group presented the worst results with reduced flow and 
increased osmolality rate. Regarding cytokines the CP 
group also presented significantly higher values for TNF 
α, IL10, and IL6 compared to the groups with DS and 
health ones (p-values<0.05) (Table 1).
In relation to cytokines analysis, DS and CP presented 
significantly higher values of IL-1β and IL8 compared 
to the health group (p-values<0.05) (Table 2). 
The DS and CP groups showed a higher percentage of 
the cytokines IL-1β (DS 77.3%, CP 66.7%), IL-8 (DS: 
78.1%, CP: 83.1%) and IL 10 (DS: 56.2%, CP: 64.4%) 
in relation to the control group. However, for the TNFα 
and IL6 cytokines, the CP group presented a higher per-
centage of these cytokines (TNFα: 87.5%; IL6: 83.9%) 
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Age (mean±SD) 17.2±3.5 16.7±3.1 16.2±3.5 0.328b
OHI-S 1.58±0.95 A 1.68±0.66 A 0.68±0.59 B 0.034 b,*
Gingival Marginal Bleed-
ing  
35.26±23.99 A 21.61±15.78 B 12.29±4.69 C <0.001b,*
Salivary flow (mL/minute) 0.28±0.23 A 0.19±0.08 B 0.36±0.14 C <0.001 b,*
Salivary Osmolality 
(mOsml/kg H2O)
118.41±32.69 A 137.13±20.80 B 85.55±10.73 C <0.001 b,*
Table 1: Distribution of individuals with Down syndrome, cerebral palsy and health ones with gingivitis, according to gender, age, oral 
hygiene, gingival marginal bleeding, salivary flow and osmolality rates evaluated.
Uppercase letters compare values horizontally (intergroups evaluation, Down syndrome vs. Cerebral palsy vs Controls). a Chi-square test; 
b ANOVA One-Way. *Statistically significant correlation at p<0.05.
Discussion 
To the best of our knowledge, this is the first study to 
evaluate and compare the salivary concentrations of in-
flammatory cytokines TNF-α, IL-1β, IL-6, IL-8, IL-10, 
and IL-12p70 in the saliva of individuals with DS, CP 
and health ones. Both DS and CP are considered disa-
bilities, and have certain characteristics in common. 
Individuals with these conditions are likely to face life-
long challenges, including physical challenges, mental 
and oral health issues (14). Higher IOH-S levels were 
observed in subjects with DS and CP in relation to heal-
thy individuals. Intellectual and physical disabilities are 
the main factors that interfere in the performance of oral 
hygiene, facilitating the accumulation of biofilm and 
consequently periodontal disease. Thus, it is necessary 
for these individuals a rigid biofilm control, oral hygie-
ne instructions with toothbrushes with adaptations that 
facilitate brush handling not only for individuals with 
impairment but also for their caregiver, and   preventive 








IL12p70 0.01±0.06 0.17±0.42 0.01± 0.04 0.322c
TNFα 1.45±1.92 A 7.26±3.22 B 0.91± 0.62 A <0.001c,*
IL10 0.07±0.19 A 0.45±0.98 B 0.16±0.59 A 0.008c,*
IL6 9.50±10.21 A 29.42± 35.25 B 4.74 ± 4.26 A 0.002c,*
 IL1β 357.14±433.72 A 243.79±24.02 A 81.54±35.47.18 B 0.003c,*
IL8 320.79±465.39 A 413.90 ±427.96 A 70.66±14.29 B <0.001c,*
Table 2: Distribution of individuals with Down syndrome, cerebral palsy and health ones with   gingivitis, according to cytokines evalu-
ated.
Uppercase letters compare values horizontally (intergroups evaluation, Down syndrome vs. Cerebral palsy vs Controls). c Kruskal Wallis 
Post Hoc Dunn test. *Statistically significant correlation at p<0.05.
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Gingival bleeding showcases important information re-
garding the presence of periodontal inflammation and 
has been used as a parameter for clinical evaluation 
(19). A significant higher value of gingival bleeding was 
observed in individuals with DS. These results corrobo-
rate with findings in the literature related to poor oral 
hygiene, the compromised immune system and reduced 
neutrophil chemotaxis in individuals with DS (6).
Among the functions of saliva are the mechanical clea-
ning and protective functions, essential for the mainte-
nance of oral health (20). The volume of salivary flow 
and the expression of salivary osmolality contribute to 
the integrity of dental elements and periodontal health. In 
this study, it was observed significantly reduced values 
of salivary flow and high values of salivary osmolality in 
individuals with CP. These conditions predispose to bac-
terial accumulation and increase gingival inflammation 
(21) when compared to DS and health individuals.
Inflammatory cytokines can be evaluated in serum (13) 
or in saliva (11). In the case of individuals with disabili-
ty, blood collection to evaluate inflammatory cytokines 
is generally not an easy task. Furthermore, individuals 
with CP present sympathetic predominance (22), resul-
ting in vasoconstriction, making venous access more di-
fficult. In this way, saliva has been used since it is ease 
to collect, contain ions, proteins, immunoglobulins and 
inflammatory biomarkers (12). Another important point 
in relation to salivary cytokine analysis is that it may 
indicate the local secretion of these mediators leading 
to a better comprehension of the gingival inflammatory 
status.
The presence of periodontal disease results of the inte-
raction of microbial agents, host defense mechanisms, 
genetic and environmental factors (23). High levels of 
IL-1β were found in saliva of individuals with DS and 
CP in the present study. The secretion of this cytokine is 
related to cellular alterations such as caspase-1 activa-
tion, an important component of inflammation and the-
refore, leading to activation of inflammatory cells (24). 
In addition, the neutrophils activation in inflamed gingi-
val tissue may result from the action of IL-1β. The group 
composed of healthy individuals presented significantly 
lower values of IL-1β, which could indicate a decrease 
in neutrophil activation, which characterizes a reduced 
inflammatory process. These results suggest the invol-
vement of IL-1β in the pathogenesis and progression of 
periodontal disease, mainly in individuals with DS due 
to the increased susceptibility to infections, and compro-
mised immune system (25).
Individuals with DS presented similar values for IL-10, 
TNFα and IL6 when compared to the control group. 
However, elevated levels of TNF-α, IL10, IL-6, IL-1β 
and IL-8 were observed in the CP group, which may in-
crease the susceptibility and progression of periodontal 
disease in these individuals (10). In fact, TNF-α and IL-6 
are correlated with the clinical indicators of periodontitis 
severity as demonstrated by previous studies (26). These 
cytokines are involved with induction of adhesion mole-
cules that facilitate leukocytes recruitment and augment 
the inflammatory response, the stimulation of matrix 
metalloproteinase, and finally bone resorption.  
It was observed a significant difference of IL-8 secretion 
for DS and CP groups in relation to control group. The 
expression of this chemokine indicates the presence of 
an inflammatory process, signaling the progression of 
periodontal disease to apical periodontitis (27,28) for 
both groups. This chemokine promotes the recruitment 
of neutrophils (29), the first line of defense for periodon-
topathogen bacteria and allows the cell to affect phago-
cytosis and destruction of microorganisms through the 
production of reactive oxygen species and proteolytic 
enzymes (30).
These findings provide a possible reason of why indi-
viduals with cerebral palsy are at higher risk to develop 
periodontal diseases. Further research is needed in order 
to integrate the results with tailored clinical treatment 
for these patients. The limitations of this study are the 
use of convenience samples and the absence of inflam-
matory cytokines determination in serum. 
Individuals with cerebral palsy present higher risk to 
develop periodontal disease due to the reduced salivary 
flow rate, increased salivary osmolality rate and eleva-
ted levels of TNFα, IL-10, IL-6 compared to individuals 
with individuals with Down syndrome.
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